Related Experiment Video
Updated: Jul 16, 2025
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
RNA-based medicine: from molecular mechanisms to therapy
Anke Sparmann1, Jörg Vogel1,2
1Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
The EMBO Journal
|September 20, 2023
Summary
RNA medicines, including mRNA vaccines, are revolutionizing disease treatment. This review covers various RNA therapeutic strategies and their clinical opportunities and challenges, using rare genetic diseases as examples.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- RNA-based therapeutics offer transformative potential for treating and preventing human diseases.
- Early research challenges paved the way for significant advancements, notably the rapid development of mRNA vaccines during the COVID-19 pandemic.
- RNA medicines are at a critical juncture, poised for broad clinical application.
Purpose of the Study:
- To provide a comprehensive overview of diverse RNA-based therapeutic strategies.
- To examine the opportunities and challenges associated with the clinical application of RNA medicines.
- To illustrate the potential impact of RNA therapeutics using rare genetic diseases as case studies.
Main Methods:
- Review of established and emerging RNA-based therapeutic modalities.
- Analysis of antisense and RNA interference (RNAi) mechanisms.
- Exploration of messenger RNA (mRNA)-based approaches and CRISPR-Cas-mediated genome editing.
Main Results:
- Identified multiple RNA-based strategies for novel therapeutic development.
- Highlighted the successful application of RNA therapeutics, exemplified by mRNA vaccines.
- Detailed the specific opportunities and challenges for applying RNA medicines to rare genetic diseases.
Conclusions:
- RNA medicines represent a powerful and versatile class of therapeutics with broad clinical potential.
- Overcoming existing challenges is crucial for the widespread adoption of RNA-based treatments.
- Further research and development are essential to fully realize the promise of RNA therapeutics for various diseases.
Keywords:
CRISPR-Cas therapyRNA interferenceantisense oligonucleotide drugmRNA therapeuticsrare genetic diseaseMore Related Videos
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
02:30siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
00:59Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K